EMA Policy 0070: Advanced Strategies for Compliance, Anonymization, and CCI Justification
April 9, 2026
As European Medicines Agency Policy 0070 enters its expanded Step 2 phase, sponsors face increased document volumes, heightened transparency obligations, and greater scrutiny of anonymization and CCI decisions. This session explores the realities of advanced Policy 0070 compliance, strategies to...